Hematology

Langerhans Cell Histiocytosis

Questions discussed in this category

In the era of MEK inhibitors and BRAF V600E-targeted therapy, what is the role of traditional vinorelbine/prednisone in the management of Langerhans cell histiocytosis?

1 Answer available

Papers discussed in this category

Blood, 2008-03-01

Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification.

Blood, 2013 Jun 20

Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.

Medical and pediatric oncology, 1994

LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.

Haematologica, 2024 Apr 01

Dabrafenib and trametinib in Langerhans cell histiocytosis and other histiocytic disorders.

Haematologica, 2024 Apr 01

First-line MAPK inhibition in pediatric histiocytosis: are we ready?

Related Topics in Hematology